Inactivation of exopolysaccharide and 3-hydroxypropionaldehyde-producing lactic acid bacteria in apple juice and apple cider by enterocin AS-48.
The bacteriocin enterocin AS-48 was tested against exopolysaccharide producing lactic acid bacteria (LAB) strains of Lactobacillus collinoides, Lactobacillus dioliovorans and Pediococcus parvulus as well as two 3-hydroxypropionaldehyde (3-HPA)-producing Lb. collinoides strains causing apple cider spoilage. In fresh-made apple juice, a bacteriocin concentration of 2.5 microg/ml reduced the LAB viable cell counts below detection levels during the course of incubation at 10 and 22 degrees C for most strains tested, except for Lb. collinoides 5 and Lb. dioliovorans 29. These two strains were significantly inhibited at 10 degrees C by 5 microg/ml AS-48 or completely inactivated at 22 degrees C. In a commercial Basque apple cider, the added bacteriocin (2.5 microg/ml for Lb. collinoides strains 9 and 10, and 5 microg/ml for the rest of strains) completely inactivated all LAB strains tested during storage at 10 as well as 22 degrees C. In the commercial Asturian apple cider tested the LAB strains showed a poor capacity for survival, but the added bacteriocin was equally effective in reducing the numbers of survivors. When a cocktail of the five LAB strains was tested in commercial Basque apple cider, viable cell counts were reduced below detection levels after 2 days for a bacteriocin concentration of 12.5 microg/ml regardless of storage temperature. Comparison of RAPD-PCR profiles revealed that strain Lb. dioliovorans 29 was always the predominant survivor detected in bacteriocin-treated samples.
Martínez-Viedma
Pilar
P
Area de Microbiología, Departamento de Ciencias de la Salud, Facultad de Ciencias Experimentales, Universidad de Jaén, Jaén, Spain.
Abriouel
Hikmate
H
Omar
Nabil Ben
NB
Valdivia
Eva
E
López
Rosario Lucas
RL
Gálvez
Antonio
A
D001430:Bacteriocins / Q000494:pharmacology*; D001628:Beverages; D005985:Glyceraldehyde / Q000031:analogs & derivatives* / Q000378:metabolism; D007778:Lactobacillus / Q000187:drug effects* / Q000378:metabolism; D027845:Malus; D010376:Pediococcus / Q000187:drug effects* / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis*; D011407:Propane / Q000378:metabolism*; D019105:Random Amplified Polymorphic DNA Technique
D001430:Bacteriocins; D011135:Polysaccharides, Bacterial; C466236:enterocin AS-48, Enterococcus faecalis; C047158:3-hydroxypropionaldehyde; D005985:Glyceraldehyde; D011407:Propane